1.Fenaux P, Chevret S, Guerci A, Fegueux N, Dombret H, Thomas X, et al. Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia 2000;14:1371–7. [CrossRef]

2. Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Woods WG, et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 2002;100:4298–302. [CrossRef]

3. Evans GD, Grimwade DJ. Extramedullary disease in acute promyelocytic leukemia. Leuk Lymphoma 1999;33:219–29.

4. Liso V, Specchia G, Pogliani EM, Palumbo G, Mininni D, Rossi V, et al. Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. Cancer 1998;83:1522–8. [CrossRef]

5. Sanz MA, Larrea L, Sanz G, Martín G, Sempere A, Gomis F, et al. Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia? Haematologica 2000;85:758–62.

6. Specchia G, Lo Coco F, Vignetti M, Avvisati G, Fazi P, Albano F, et al. Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. J Clin Oncol 2001;19:4023–8. [CrossRef]

7. Breccia M, Carmosino I, Diverio D, De Santis S, De Propris MS, Romano A, et al. Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presenting leucocyte count. Br J Haematol 2003;120:266–70. [CrossRef]

8. Breccia M, Petti MC, Testi AM, Specchia G, Ferrara F, Diverio D, et al. Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'? Leukemia 2002;16:1127–30. [CrossRef]

9. Kelaidi C, Ades L, Chevret S, Sanz M, Guerci A, Thomas X, et al. Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials). Leukemia 2006;20:905–7. [CrossRef]